16 feb. 2026
Garcia et al. (BioRxiv)
Keywords
Immune checkpoint inhibition
Type-2 immunity
Tissue regeneration
Main Findings
Extracellular matrix (ECM)-derived scaffolds induce type-2 immune responses that favour tissue regeneration. However, how inhibitory immune signalling pathways, such as checkpoint molecules, integrate with these pro-regenerative environments remains incompletely characterized. Garcia et al. address this gap using murine models of volumetric muscle loss, revealing that immune checkpoint signalling is actively engaged within healing niches and meaningfully shapes the ensuing immune landscape.
In ECM-treated wounds, the authors report checkpoint molecule expression across multiple lineages. LAG-3 is prominent on both type-2 helper T (Th2) cells and regulatory T (Treg) cells, while PD-L2 is expressed on macrophages within regenerating tissue. Rather than indicating dysfunction or exhaustion, checkpoint expression in this repair context coincides with a type-2 cytokine milieu and alternative macrophage activation, suggesting that checkpoint signalling serves a regulatory, rather than suppressive, role during regeneration.
Fate-mapping and cytokine reporter systems further reveal notable plasticity within the CD4⁺ T cell compartment. Within the regenerative niche, Tregs lose canonical features and acquire characteristics of Th2-like “ex-Treg” cells. This phenotypic shift highlights the flexibility of immune states during tissue repair and challenges rigid delineations between canonical T cell subsets.
When checkpoint signalling is inhibited, this regenerative immune programme is amplified. Blockade of LAG-3–associated pathways enhances the transition of Tregs toward Th2-like phenotypes, increases Th2 cell representation, and promotes the accumulation of alternatively activated macrophages. These immune shifts coincide with improved physiological outcomes, including reduced fibrotic deposition and enhanced markers of muscle regeneration.
Collectively, the study suggests that immune checkpoint pathways, long studied for their role in mitigating cytotoxic responses in cancer, also modulate context-specific immune states. In regenerative settings such as ECM-mediated repair, checkpoint signalling appears to orchestrate the balance between type-2 immunity and tissue remodelling. Although the molecular mechanisms linking checkpoint activity to Treg reprogramming and macrophage polarization remain unresolved, this work reframes inhibitory signalling as a regulator of immune cell identity during tissue repair. By bridging immunotherapy concepts with regenerative biology, the preprint invites further exploration of how checkpoint modulation might be harnessed to optimise healing in biomaterial and other non-malignant contexts.
Limitations & Suggestions
While the study compellingly positions checkpoint signalling within regenerative immune programmes, several mechanistic questions remain. The molecular pathways linking checkpoint activity to Treg reprogramming are not delineated, and it is unclear whether the observed Th2-like “ex-Treg” state reflects stable lineage conversion or a transient adaptation to the wound milieu. The extent to which antigen-presenting cells mediate checkpoint-dependent CD4⁺ T cell modulation, particularly given PD-L2 expression on macrophages, also warrants further investigation. Moreover, although checkpoint inhibition enhances repair in this model, defining the temporal window during which modulation is beneficial, without provoking excessive inflammation, will be essential for translation. Translating these findings to human biology and situating these pathways within established type-2 cytokine networks would further clarify how inhibitory signalling tunes immune cell identity during tissue repair.
Significance & Novelty
This preprint broadens the conceptual scope of immune checkpoint biology beyond its established role in cancer immunotherapy by supporting that inhibitory pathways also help shape regenerative type-2 immune programmes. By revealing plasticity between Tregs and Th2 cells in a wound-healing context, the study highlights how local environmental cues tune immune cell states. The authors position checkpoint signalling not only as a brake on cytotoxic responses, but as a regulator of cell identity and intercellular communication during tissue repair. These insights are pertinent to regenerative medicine and biomedical engineering, suggesting that targeted modulation of inhibitory signalling could refine strategies to enhance homeostatic immunity in non-malignant settings. More broadly, the findings prompt reconsideration of how checkpoint pathways intersect with cytokine networks and immune cell plasticity across inflammatory and repair contexts.
Credit
Reviewed by Sinibaldo Romero Arocha as part of a cross-institutional journal club between the University of Oxford, the Icahn School of Medicine at Mount Sinai, The University of Texas MD Anderson Cancer Center, the Karolinska Institute, and the University of Toronto.
The author declares no conflict of interests in relation to their involvement in the review.